7TM Pharma A/S

The US obesity market is set to grow from $533m to $1.2bn in the next 10 years, according to Datamonitor Healthcare’s obesity forecast . However, there is room for more dramatic growth long term sh

Cancer Research Technology, the commercial arm of Cancer Research UK, has appointed Peter Chambré chair of the board. Mr Chambré is currently chairman of Xellia Pharmaceuticals and 7TM Pharma and a no

Zealand Pharma, a Danish biopharmaceutical company developing innovative peptide drugs, has appointed Dr Arvind Hundal senior vice-president and chief business officer. Dr Hundal joined Zealand Pharma

Astellas has begun considering strategic options for the future of its UK R&D subsidiary Prosidion, which it acquired last year as part of the purchase of OSI Pharmaceuticals but now apparently consid